- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04789746
Ready, Set, Go! A Physical Fitness Intervention for Children With Mobility Challenges
August 15, 2026 updated by: Theresa Moulton, Northwestern University
Barriers to keeping and maintaining fitness as a young person with a disability exist across many domains of access to community locations such as fitness centers, so looking outside of these establishments may be necessary to advance fitness.
This study is aimed at piloting a program that would address some of these barriers by hosting a modified after school running program with an underserved population in an accessible way.
There is a second option to participate outside of school.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago Heights, Illinois, United States, 60611
- Northwestern University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- a medical diagnosis (for example, cerebral palsy) that causes them mobility limitations
Exclusion Criteria:
- concurrent medical condition that would make exercise unsafe,
- are unable to follow simple commands
- have behaviors that would potentially compromise safety of fellow runners or caregivers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Running group
Participants that will join the running program.
|
The intervention being piloted is a 6-8 week running program modified from a running curriculum designed for school-aged children.
The children will use a RaceRunner device to facilitate their participation, but this device is not explicitly evaluated in this study.
Depending on transportation, they may be given access to the device in their home or school between sessions after it has been fit for them.
If given access, guardians will be instructed on care and usage.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Goal attainment scale
Time Frame: at 8 weeks.
|
a tool designed to standardize the setting and scaling of goals in a way that allows for both improvement and regression as a result of intervention.
|
at 8 weeks.
|
|
6 min walk test
Time Frame: baseline
|
Participant will walk as far as they can in 6 minutes, as a measure of endurance
|
baseline
|
|
6 min walk test
Time Frame: at 8 weeks
|
Participant will walk as far as they can in 6 minutes, as a measure of endurance
|
at 8 weeks
|
|
30 second walk test
Time Frame: baseline
|
Participant will walk as fast as they can for 30 seconds, as a measure of speed.
|
baseline
|
|
30 second walk test
Time Frame: at 8 weeks
|
Participant will walk as fast as they can for 30 seconds, as a measure of speed.
|
at 8 weeks
|
|
Resting heart rate
Time Frame: baseline
|
Participant heart rate after 5 minutes of quiet sitting
|
baseline
|
|
Resting heart rate
Time Frame: at 8 weeks
|
Participant heart rate after 5 minutes of quiet sitting
|
at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surveys
Time Frame: baseline
|
Participants and their parents will answer questions about baseline level of activity, their perception of themselves, and areas of personal strength
|
baseline
|
|
Surveys
Time Frame: at 8 weeks
|
Participants and their parents will answer questions about baseline level of activity, their perception of themselves, and areas of personal strength
|
at 8 weeks
|
|
Selective Control Assessment of the Lower Extremity (SCALE)
Time Frame: baseline
|
a method of assessing the ability of a participant to isolate motion to an individual joint of the lower extremity.
Min score=0; max score=16, a higher score is a better outcome
|
baseline
|
|
Selective Control Assessment of the Lower Extremity (SCALE)
Time Frame: at 8 weeks
|
a method of assessing the ability of a participant to isolate motion to an individual joint of the lower extremity Min score=0; max score=16, a higher score is a better outcome
|
at 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 20, 2019
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
March 3, 2021
First Submitted That Met QC Criteria
March 5, 2021
First Posted (Actual)
March 10, 2021
Study Record Updates
Last Update Posted (Actual)
August 18, 2026
Last Update Submitted That Met QC Criteria
August 15, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Musculoskeletal Diseases
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Muscular Diseases
- Mental Disorders
- Joint Diseases
- Musculoskeletal Abnormalities
- Congenital Abnormalities
- Neurodevelopmental Disorders
- Brain Damage, Chronic
- Nervous System Malformations
- Neural Tube Defects
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Cerebral Palsy
- Arthrogryposis
- Motor Skills Disorders
- Meningomyelocele
Other Study ID Numbers
- STU00209443
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.